311 related articles for article (PubMed ID: 26252008)
21. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
Shah E; Kim S; Chong K; Lembo A; Pimentel M
Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104
[TBL] [Abstract][Full Text] [Related]
22. Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
Qi Q; Zhang Y; Chen F; Zuo X; Li Y
BMC Gastroenterol; 2018 Jan; 18(1):5. PubMed ID: 29310568
[TBL] [Abstract][Full Text] [Related]
23. Antidepressants plus benzodiazepines for adults with major depression.
Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis.
Rahimi R; Nikfar S; Rezaie A; Abdollahi M
World J Gastroenterol; 2009 Apr; 15(13):1548-53. PubMed ID: 19340896
[TBL] [Abstract][Full Text] [Related]
25. Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome.
Bundeff AW; Woodis CB
Ann Pharmacother; 2014 Jun; 48(6):777-84. PubMed ID: 24651166
[TBL] [Abstract][Full Text] [Related]
26. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
27. Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents.
Kaminski A; Kamper A; Thaler K; Chapman A; Gartlehner G
Cochrane Database Syst Rev; 2011 Jul; 2011(7):CD008013. PubMed ID: 21735420
[TBL] [Abstract][Full Text] [Related]
28. Treatment of irritable bowel syndrome.
Trinkley KE; Nahata MC
J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
[TBL] [Abstract][Full Text] [Related]
29. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
30. Antidepressants in IBS: are we deluding ourselves?
Talley NJ
Am J Gastroenterol; 2004 May; 99(5):921-3. PubMed ID: 15128361
[TBL] [Abstract][Full Text] [Related]
31. Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.
Ford AC; Lacy BE; Harris LA; Quigley EMM; Moayyedi P
Am J Gastroenterol; 2019 Jan; 114(1):21-39. PubMed ID: 30177784
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Functional Abdominal Pain With Antidepressants: Benefits, Adverse Effects, and the Gastroenterologist's Role.
Zar-Kessler CAM; Belkind-Gerson J; Bender S; Kuo BM
J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):16-21. PubMed ID: 28644344
[TBL] [Abstract][Full Text] [Related]
33. Antidepressants for pain management in rheumatoid arthritis.
Richards BL; Whittle SL; Buchbinder R
Cochrane Database Syst Rev; 2011 Nov; (11):CD008920. PubMed ID: 22071859
[TBL] [Abstract][Full Text] [Related]
34. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
35. Fluoxetine versus other types of pharmacotherapy for depression.
Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
[TBL] [Abstract][Full Text] [Related]
36. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
37. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
39. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants.
De Vries C; Gadzhanova S; Sykes MJ; Ward M; Roughead E
Drug Saf; 2021 Mar; 44(3):291-312. PubMed ID: 33354752
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
